User profiles for P. A. MacDONALD
Penny A. MacDonaldBrain and Mind Institute, University of Western Ontario Verified email at lhsc.on.ca Cited by 3445 |
Interdimensional interference in the Stroop effect: Uncovering the cognitive and neural anatomy of attention
CM MacLeod, PA MacDonald - Trends in cognitive sciences, 2000 - cell.com
In the classic Stroop effect, naming the color of an incompatible color word (eg the word RED
printed in green ink; say, ‘green') is much slower and more error-prone than is naming the …
printed in green ink; say, ‘green') is much slower and more error-prone than is naming the …
Decision making in the multiligament-injured knee: an evidence-based systematic review
…, GC Fanelli, MJ Stuart, JL Boyd, PA MacDonald… - … : The Journal of …, 2009 - Elsevier
PURPOSE: The purpose of this systematic review was to address the treatment of multiligament
knee injuries, specifically (1) surgical versus nonoperative treatment, (2) repair versus …
knee injuries, specifically (1) surgical versus nonoperative treatment, (2) repair versus …
Controversies in the treatment of knee dislocations and multiligament reconstruction
…, DB Whelan, JP Stannard, PA MacDonald… - JAAOS-Journal of the …, 2009 - journals.lww.com
… MacDonald or a member of his immediate family has received research or institutional support
from Linvatec and is a consultant to or an employee of Linvatec. Dr. Stuart or a member of …
from Linvatec and is a consultant to or an employee of Linvatec. Dr. Stuart or a member of …
[HTML][HTML] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
…, RL Wortmann, PA MacDonald… - … England Journal of …, 2005 - Mass Medical Soc
Background Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, is a
potential alternative to allopurinol for patients with hyperuricemia and gout. Methods We …
potential alternative to allopurinol for patients with hyperuricemia and gout. Methods We …
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28‐week, phase III, randomized, double‐blind …
…, RL Wortmann, PA MacDonald… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To compare the urate‐lowering efficacy and safety of febuxostat, allopurinol, and
placebo in a large group of subjects with hyperuricemia and gout, including persons with …
placebo in a large group of subjects with hyperuricemia and gout, including persons with …
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose …
…, RL Wortmann, PA MacDonald… - Arthritis & …, 2005 - Wiley Online Library
Objective Gout affects ∼1–2% of the American population. Current options for treating
hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and …
hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and …
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
…, MA Becker, E Lloyd, PA MacDonald… - …, 2009 - academic.oup.com
Objectives. This 5-yr study assessed urate-lowering and clinical efficacy and safety of long-term
febuxostat therapy in subjects with gout. The primary efficacy end-point was reduction to …
febuxostat therapy in subjects with gout. The primary efficacy end-point was reduction to …
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout
MA Becker, HR Schumacher, PA MacDONALD… - The Journal of …, 2009 - jrheum.org
Objective. To determine longterm urate-lowering efficacy and clinical benefits and safety of
therapy with febuxostat or allopurinol in subjects with gout. Methods. Subjects (n = 1086) in …
therapy with febuxostat or allopurinol in subjects with gout. Methods. Subjects (n = 1086) in …
Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer
…, AA Grosset, Z Dong, C Russo, PA MacDonald… - Clinical cancer …, 2010 - AACR
Purpose: Although the murine orthologue of glycoprotein nonmetastatic B (GPNMB),
Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance in …
Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance in …
Memory and confidence in memory judgments among individuals with obsessive compulsive disorder and non-clinical controls
The present study investigated episodic memory functioning in: (1) obsessive compulsive
disorder (OCD) patients with primarily checking symptoms (ie checkers); (2) OCD patients …
disorder (OCD) patients with primarily checking symptoms (ie checkers); (2) OCD patients …